Skip to main content
x

INNOVATION THROUGH TECHNOLOGY

Neurelis was founded in 2007 with a vow to provide progressive solutions in therapeutic care to address unmet needs. Our technologies help to accelerate product development and enhance drug performance. By optimizing the development pathway and improving product performance, we empower people and their healthcare providers with a broader array of treatment options.

Neurelis Technology Portfolio

Intravail logo and blurb

Intravail logo and blurb

Intravail®

The science of Intravail® enables the non-invasive delivery of a broad range of protein, peptide, and non-peptide drugs, including small molecules. Intravail® can be utilized via the oral, buccal, dermal, and intranasal routes of administration, providing several advantages.

SEE HOW INTRAVAIL® OPTIMIZES ABSORPTION

THE ADVANTAGES OF INTRAVAIL®:

  • Increased bioavailability

    Addressing sub-optimal drug absorption

  • Application to wide range of molecules

    Small molecules, therapeutic proteins, peptides, non-peptide macromolecules (up to ~ 30KDa)

  • Safety

    Odorless, tasteless, non-toxic, non-mutagenic, and non-irritating

  • Solubility in water and oils

    Compatible with routine liquid formulation and dispensing processes for ease of scale-up and production

Protek® logo and blurb

Protek® logo and blurb

Protek®

ProTek protein technology aids in stabilization that prevents the clustering of proteins and peptides, thus reducing immunogenicity. ProTek allows the creation of easily manufacturable, homogeneous, stable, aqueous or lyophilized dosage forms for therapeutics that maintain the structural integrity and physiological activity of many protein and peptide drugs. Formulations are applicable to injectable, intranasal, and other dosage forms.

CONTACT US ABOUT LICENSING PROTEK

Hydrogel™ logo and blurb

Hydrogel™ logo and blurb

Hydrogel™

Hydrogel is an absorption-enhancing water-based gel used for transdermal and transmucosal drug delivery applications. Hydrogel serves simultaneously as a delivery vehicle and absorption enhancer. In dermal applications, Hydrogel leaves the skin feeling soft without residue. The thixotropic nature of Hydrogel prevents dripping and running when dispensing, which allows the gel to self-stabilize as soon as it is applied to the affected area.

CONTACT US ABOUT LICENSING HYDROGEL

Supporting Publications

Download the supporting publications below for more information on the Neurelis Technology Portfolio

Bioequivalence of biotherapeutics – looking beyond bioavailability and pharmacodynamics DOWNLOAD PDF

Circumventing polysorbate induced unwanted immunogenicity and anaphylaxis DOWNLOAD PDF

Reducing or eliminating polysorbate induced anaphylaxis and unwanted immunogenicity in biotherapeutics DOWNLOAD PDF

Polysorbates, biotherapeutics, and anaphylaxis DOWNLOAD PDF

Alkyl mono- and diglucosides: highly effective, nonionic surfactant replacements for polysorbates in biotherapeutics—a review DOWNLOAD PDF

Absorption enhancing excipients in nasal drug delivery DOWNLOAD PDF

Biosimilars, oxidative damage, and unwanted immunogenicity DOWNLOAD PDF

Highly bioavailable nasal calcitonin – potential for expanded use in analgesia DOWNLOAD PDF

Novel excipients prevent aggregation in manufacturing and formulation of protein and peptide therapeutics DOWNLOAD PDF

LICENSE OUR TECHNOLOGY AND MAKE YOUR VISION A REALITY

PARTNER WITH US
SEE OUR PARTNERS